• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恒定链区分外源性和内源性抗原呈递途径。

Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways.

作者信息

Teyton L, O'Sullivan D, Dickson P W, Lotteau V, Sette A, Fink P, Peterson P A

机构信息

Department of Immunology, Research Institute of Scripps Clinic, La Jolla, California 92037.

出版信息

Nature. 1990 Nov 1;348(6296):39-44. doi: 10.1038/348039a0.

DOI:10.1038/348039a0
PMID:2234057
Abstract

Class I MHC molecules acquire peptides from endogenously synthesized proteins, whereas class II antigens present peptides derived from extracellular compartment molecules. This dichotomy is due to the fact that the invariant chain associates with class II molecules in the endoplasmic reticulum, preventing binding of endogenous peptides. The mutually exclusive binding of peptide and invariant chain to class II molecules suggests that the invariant chain might play a part in autoimmune disease.

摘要

I类主要组织相容性复合体(MHC)分子从内源性合成的蛋白质中获取肽段,而II类抗原呈递来自细胞外区室分子的肽段。这种二分法是由于恒定链在内质网中与II类分子结合,从而阻止内源性肽段的结合。肽段和恒定链与II类分子的相互排斥结合表明恒定链可能在自身免疫性疾病中起作用。

相似文献

1
Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways.恒定链区分外源性和内源性抗原呈递途径。
Nature. 1990 Nov 1;348(6296):39-44. doi: 10.1038/348039a0.
2
Invariant chain prevents the HLA-DR-restricted presentation of a cytosolic peptide.恒定链可阻止细胞溶质肽通过HLA-DR限制的方式进行呈递。
J Immunol. 1994 Aug 15;153(4):1487-94.
3
Antigen presentation enhanced by the alternatively spliced invariant chain gene product p41.通过可变剪接的恒定链基因产物p41增强的抗原呈递。
Nature. 1992 Jun 18;357(6379):596-8. doi: 10.1038/357596a0.
4
Poor loading of major histocompatibility complex class II molecules with endogenously synthesized short peptides in the absence of invariant chain.在缺乏恒定链的情况下,主要组织相容性复合体II类分子与内源性合成的短肽的装载不佳。
Eur J Immunol. 1995 Jan;25(1):48-53. doi: 10.1002/eji.1830250110.
5
Diminished class II-associated Ii peptide binding to the juvenile dermatomyositis HLA-DQ alpha 1*0501/DQ beta 1*0301 molecule.II类相关Ii肽与青少年皮肌炎HLA-DQα1*0501/DQβ1*0301分子的结合减少。
J Immunol. 1997 Dec 15;159(12):6260-5.
6
Acquisition of peptides by MHC class II polypeptides in the absence of the invariant chain.在缺乏恒定链的情况下,MHC II类多肽对肽段的获取
J Immunol. 1995 Feb 1;154(3):1048-56.
7
Invariant chain peptides enhancing or inhibiting the presentation of antigenic peptides by major histocompatibility complex class II molecules.不变链肽增强或抑制主要组织相容性复合体II类分子对抗原肽的呈递。
Eur J Immunol. 1995 Jun;25(6):1693-702. doi: 10.1002/eji.1830250632.
8
Inhibition by brefeldin A of presentation of exogenous protein antigens to MHC class II-restricted T cells.布雷菲德菌素A对外源蛋白抗原呈递给MHC II类限制性T细胞的抑制作用。
Nature. 1990 Jul 5;346(6279):63-6. doi: 10.1038/346063a0.
9
Efficient internalization of MHC class II-invariant chain complexes is not sufficient for invariant chain proteolysis and class II antigen presentation.MHC II类分子-恒定链复合物的有效内化不足以进行恒定链蛋白水解和II类抗原呈递。
J Immunol. 1995 Jul 15;155(2):630-43.
10
Invariant chain association with MHC class I: preference for HLA class I/beta 2-microglobulin heterodimers, specificity, and influence of the MHC peptide-binding groove.恒定链与MHC I类分子的结合:对HLA I类分子/β2-微球蛋白异二聚体的偏好、特异性以及MHC肽结合槽的影响
J Immunol. 1996 Nov 15;157(10):4503-10.

引用本文的文献

1
Reduced MHC Class I and II Expression in HPV-Negative vs. HPV-Positive Cervical Cancers.HPV 阴性与 HPV 阳性宫颈癌中 MHC Ⅰ类和Ⅱ类分子的表达降低。
Cells. 2022 Dec 3;11(23):3911. doi: 10.3390/cells11233911.
2
Antigen Presentation in the Lung.肺部的抗原呈递。
Front Immunol. 2022 May 9;13:860915. doi: 10.3389/fimmu.2022.860915. eCollection 2022.
3
Drug-Induced Severe Cutaneous Adverse Reactions: Insights Into Clinical Presentation, Immunopathogenesis, Diagnostic Methods, Treatment, and Pharmacogenomics.药物性严重皮肤不良反应:对临床表现、免疫发病机制、诊断方法、治疗及药物基因组学的见解
Front Pharmacol. 2022 Apr 20;13:832048. doi: 10.3389/fphar.2022.832048. eCollection 2022.
4
Partnering for the major histocompatibility complex class II and antigenic determinant requires flexibility and chaperons.与主要组织相容性复合体 II 和抗原决定簇合作需要灵活性和伴侣分子。
Curr Opin Immunol. 2021 Jun;70:112-121. doi: 10.1016/j.coi.2021.05.005. Epub 2021 Jun 17.
5
CD1a selectively captures endogenous cellular lipids that broadly block T cell response.CD1a选择性捕获内源性细胞脂质,这些脂质广泛阻断T细胞反应。
J Exp Med. 2021 Jul 5;218(7). doi: 10.1084/jem.20202699. Epub 2021 May 7.
6
The Phosphoinositide Kinase PIKfyve Promotes Cathepsin-S-Mediated Major Histocompatibility Complex Class II Antigen Presentation.磷脂酰肌醇激酶PIKfyve促进组织蛋白酶S介导的主要组织相容性复合体II类抗原呈递。
iScience. 2019 Jan 25;11:160-177. doi: 10.1016/j.isci.2018.12.015. Epub 2018 Dec 20.
7
Role of lipid transfer proteins in loading CD1 antigen-presenting molecules.脂质转移蛋白在加载 CD1 抗原呈递分子中的作用。
J Lipid Res. 2018 Aug;59(8):1367-1373. doi: 10.1194/jlr.R083212. Epub 2018 Mar 19.
8
A step-by-step overview of the dynamic process of epitope selection by major histocompatibility complex class II for presentation to helper T cells.主要组织相容性复合体II类选择表位以呈递给辅助性T细胞的动态过程的逐步概述。
F1000Res. 2016 Jun 9;5. doi: 10.12688/f1000research.7664.1. eCollection 2016.
9
Antigen Processing and Presentation Mechanisms in Myeloid Cells.髓样细胞中的抗原加工和呈递机制。
Microbiol Spectr. 2016 Jun;4(3). doi: 10.1128/microbiolspec.MCHD-0008-2015.
10
Quantitating MHC class II trafficking in primary dendritic cells using imaging flow cytometry.使用成像流式细胞术对原代树突状细胞中的MHC II类分子转运进行定量分析。
J Immunol Methods. 2015 Aug;423:18-28. doi: 10.1016/j.jim.2015.04.023. Epub 2015 May 9.